Duncker Streett & CO Inc Elanco Animal Health Inc Transaction History
Duncker Streett & CO Inc
- $532 Million
- Q4 2024
A detailed history of Duncker Streett & CO Inc transactions in Elanco Animal Health Inc stock. As of the latest transaction made, Duncker Streett & CO Inc holds 13 shares of ELAN stock, worth $148. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13
Previous 13
-0.0%
Holding current value
$148
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding ELAN
# of Institutions
448Shares Held
479MCall Options Held
4.57MPut Options Held
730K-
Dodge & Cox San Francisco, CA83.3MShares$951 Million0.74% of portfolio
-
Primecap Management CO Pasadena, CA51.2MShares$584 Million0.49% of portfolio
-
Vanguard Group Inc Valley Forge, PA48.8MShares$556 Million0.01% of portfolio
-
Black Rock Inc. New York, NY23.3MShares$266 Million0.01% of portfolio
-
Black Creek Investment Management Inc. Toronto, A621.3MShares$243 Million11.09% of portfolio
About Elanco Animal Health Inc
- Ticker ELAN
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 474,113,984
- Market Cap $5.41B
- Description
- Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...